{"id":"https://openalex.org/W2106910596","doi":"https://doi.org/10.1158/2326-6066.cir-15-0044","title":"CTLA-4 Blockade Synergizes Therapeutically with PARP Inhibition in BRCA1-Deficient Ovarian Cancer","display_name":"CTLA-4 Blockade Synergizes Therapeutically with PARP Inhibition in BRCA1-Deficient Ovarian Cancer","alternate_titles":[],"publication_year":2015,"publication_date":"2015-07-03","ids":{"openalex":"https://openalex.org/W2106910596","doi":"https://doi.org/10.1158/2326-6066.cir-15-0044","mag":"2106910596","pmid":"https://pubmed.ncbi.nlm.nih.gov/26138335","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/4984269"},"language":"en","primary_location":{"id":"doi:10.1158/2326-6066.cir-15-0044","doi":"https://doi.org/10.1158/2326-6066.cir-15-0044","is_oa":false,"landing_page_url":"https://doi.org/10.1158/2326-6066.cir-15-0044","pdf_url":null,"source":{"id":"https://openalex.org/S2765010658","display_name":"Cancer Immunology Research","issn_l":"2326-6066","issn":["2326-6066","2326-6074"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Immunology Research","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2106910596"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"green","oa_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC4984269/","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5032745366","display_name":"Tomoe Higuchi","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4390039284","display_name":"UNM Comprehensive Cancer Center","ror":"https://ror.org/05kx2e072","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I169521973","https://openalex.org/I4390039284"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Tomoe Higuchi","raw_affiliation_strings":["1The University of New Mexico Cancer Center, Albuquerque, New Mexico"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1The University of New Mexico Cancer Center, Albuquerque, New Mexico","institution_ids":["https://openalex.org/I4390039284"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5043413904","display_name":"Dallas B. Flies","orcid":"https://orcid.org/0000-0002-9280-2080","observed_orcids":["https://orcid.org/0000-0002-9280-2080"]},"institutions":[{"id":"https://openalex.org/I4390039284","display_name":"UNM Comprehensive Cancer Center","ror":"https://ror.org/05kx2e072","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I169521973","https://openalex.org/I4390039284"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Dallas B. Flies","raw_affiliation_strings":["1The University of New Mexico Cancer Center, Albuquerque, New Mexico"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1The University of New Mexico Cancer Center, Albuquerque, New Mexico","institution_ids":["https://openalex.org/I4390039284"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5071419960","display_name":"Nicole A. Marjon","orcid":"https://orcid.org/0000-0001-9963-5943","observed_orcids":["https://orcid.org/0000-0001-9963-5943"]},"institutions":[{"id":"https://openalex.org/I4390039284","display_name":"UNM Comprehensive Cancer Center","ror":"https://ror.org/05kx2e072","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I169521973","https://openalex.org/I4390039284"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Nicole A. Marjon","raw_affiliation_strings":["1The University of New Mexico Cancer Center, Albuquerque, New Mexico"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1The University of New Mexico Cancer Center, Albuquerque, New Mexico","institution_ids":["https://openalex.org/I4390039284"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5014979440","display_name":"Gina M. Mantia-Smaldone","orcid":"https://orcid.org/0000-0001-8223-3059","observed_orcids":["https://orcid.org/0000-0001-8223-3059"]},"institutions":[{"id":"https://openalex.org/I1289437631","display_name":"Fox Chase Cancer Center","ror":"https://ror.org/0567t7073","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1289437631","https://openalex.org/I4210122924"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Gina Mantia-Smaldone","raw_affiliation_strings":["2Fox Chase Cancer Center, Philadelphia, Pennsylvania"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2Fox Chase Cancer Center, Philadelphia, Pennsylvania","institution_ids":["https://openalex.org/I1289437631"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5045001893","display_name":"Lukas Ronner","orcid":"https://orcid.org/0000-0002-2310-5345","observed_orcids":["https://orcid.org/0000-0002-2310-5345"]},"institutions":[{"id":"https://openalex.org/I74973139","display_name":"Carnegie Mellon University","ror":"https://ror.org/05x2bcf33","country_code":"US","type":"education","lineage":["https://openalex.org/I74973139"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Lukas Ronner","raw_affiliation_strings":["3Carnegie Mellon University, Pittsburgh, Pennsylvania"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"3Carnegie Mellon University, Pittsburgh, Pennsylvania","institution_ids":["https://openalex.org/I74973139"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5013962604","display_name":"Phyllis A. Gimotty","orcid":"https://orcid.org/0000-0002-3850-9799","observed_orcids":["https://orcid.org/0000-0002-3850-9799"]},"institutions":[{"id":"https://openalex.org/I79576946","display_name":"University of Pennsylvania","ror":"https://ror.org/00b30xv10","country_code":"US","type":"education","lineage":["https://openalex.org/I79576946"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Phyllis A. Gimotty","raw_affiliation_strings":["4The University of Pennsylvania, Philadelphia, Pennsylvania"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"4The University of Pennsylvania, Philadelphia, Pennsylvania","institution_ids":["https://openalex.org/I79576946"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5044231660","display_name":"Sarah Foster Adams","orcid":"https://orcid.org/0000-0002-0240-1380","observed_orcids":["https://orcid.org/0000-0002-0240-1380"]},"institutions":[{"id":"https://openalex.org/I4390039284","display_name":"UNM Comprehensive Cancer Center","ror":"https://ror.org/05kx2e072","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I169521973","https://openalex.org/I4390039284"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Sarah F. Adams","raw_affiliation_strings":["1The University of New Mexico Cancer Center, Albuquerque, New Mexico"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1The University of New Mexico Cancer Center, Albuquerque, New Mexico","institution_ids":["https://openalex.org/I4390039284"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":4,"corresponding_author_ids":["https://openalex.org/A5044231660"],"corresponding_institution_ids":["https://openalex.org/I4390039284"],"apc_list":null,"apc_paid":null,"fwci":11.2393,"has_fulltext":false,"cited_by_count":292,"citation_normalized_percentile":{"value":0.99236012,"is_in_top_1_percent":true,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":99,"max":100},"biblio":{"volume":"3","issue":"11","first_page":"1257","last_page":"1268"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.8335000276565552,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.8335000276565552,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11914","display_name":"PARP inhibition in cancer therapy","score":0.15410000085830688,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10769","display_name":"BRCA gene mutations in cancer","score":0.003700000001117587,"subfield":{"id":"https://openalex.org/subfields/1311","display_name":"Genetics"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/ctla-4-blockade","display_name":"CTLA-4 blockade","score":0.9959999918937683},{"id":"https://openalex.org/keywords/parp-inhibition","display_name":"PARP inhibition","score":0.8320000171661377},{"id":"https://openalex.org/keywords/immune-checkpoint-blockade","display_name":"immune checkpoint blockade","score":0.9589999914169312},{"id":"https://openalex.org/keywords/pd-1-pd-l1-blockade","display_name":"PD-1/PD-L1 blockade","score":0.9079999923706055},{"id":"https://openalex.org/keywords/combination-immunotherapy","display_name":"combination immunotherapy","score":0.8040000200271606},{"id":"https://openalex.org/keywords/tumor-immunogenicity","display_name":"tumor immunogenicity","score":0.8479999899864197},{"id":"https://openalex.org/keywords/interferon-gamma","display_name":"interferon-gamma","score":0.7440000176429749},{"id":"https://openalex.org/keywords/t-cell-mediated-immunity","display_name":"T cell immunity","score":0.7049999833106995},{"id":"https://openalex.org/keywords/immunological-memory","display_name":"immunological memory","score":0.6959999799728394},{"id":"https://openalex.org/keywords/hereditary-ovarian-cancer","display_name":"hereditary ovarian cancer","score":0.8809999823570251}],"concepts":[{"id":"https://openalex.org/C2780427987","wikidata":"https://www.wikidata.org/wiki/Q172341","display_name":"Ovarian cancer","level":3,"score":0.702540397644043},{"id":"https://openalex.org/C2778468042","wikidata":"https://www.wikidata.org/wiki/Q273976","display_name":"Blockade","level":3,"score":0.6470443606376648},{"id":"https://openalex.org/C2780851360","wikidata":"https://www.wikidata.org/wiki/Q21686041","display_name":"Immune checkpoint","level":4,"score":0.6256875991821289},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.602368175983429},{"id":"https://openalex.org/C8891405","wikidata":"https://www.wikidata.org/wiki/Q1059","display_name":"Immune system","level":2,"score":0.5931536555290222},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.580291211605072},{"id":"https://openalex.org/C2779138821","wikidata":"https://www.wikidata.org/wiki/Q7118227","display_name":"PARP inhibitor","level":5,"score":0.5624271631240845},{"id":"https://openalex.org/C154317977","wikidata":"https://www.wikidata.org/wiki/Q376266","display_name":"Cytotoxic T cell","level":3,"score":0.5208959579467773},{"id":"https://openalex.org/C21705690","wikidata":"https://www.wikidata.org/wiki/Q2907609","display_name":"CTLA-4","level":4,"score":0.47912073135375977},{"id":"https://openalex.org/C2777701055","wikidata":"https://www.wikidata.org/wiki/Q1427096","display_name":"Immunotherapy","level":3,"score":0.47796034812927246},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.469022661447525},{"id":"https://openalex.org/C2780868878","wikidata":"https://www.wikidata.org/wiki/Q1660197","display_name":"Immunogenicity","level":3,"score":0.4628185033798218},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.4576638340950012},{"id":"https://openalex.org/C159654299","wikidata":"https://www.wikidata.org/wiki/Q79460","display_name":"Antibody","level":2,"score":0.4135555624961853},{"id":"https://openalex.org/C2780674031","wikidata":"https://www.wikidata.org/wiki/Q2012719","display_name":"Cancer immunotherapy","level":4,"score":0.41309282183647156},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.3754846155643463},{"id":"https://openalex.org/C2776090121","wikidata":"https://www.wikidata.org/wiki/Q193529","display_name":"T cell","level":3,"score":0.3633684515953064},{"id":"https://openalex.org/C182979987","wikidata":"https://www.wikidata.org/wiki/Q3907241","display_name":"Poly ADP ribose polymerase","level":4,"score":0.27785247564315796},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.2592845857143402},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.2468518316745758},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.1241198480129242},{"id":"https://openalex.org/C202751555","wikidata":"https://www.wikidata.org/wiki/Q221681","display_name":"In vitro","level":2,"score":0.10899990797042847},{"id":"https://openalex.org/C82381507","wikidata":"https://www.wikidata.org/wiki/Q416878","display_name":"Polymerase","level":3,"score":0.0},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.0},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.0}],"mesh":[{"descriptor_ui":"D000067856","descriptor_name":"Poly(ADP-ribose) Polymerase Inhibitors","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D000067856","descriptor_name":"Poly(ADP-ribose) Polymerase Inhibitors","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000911","descriptor_name":"Antibodies, Monoclonal","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D003131","descriptor_name":"Combined Modality Therapy","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D003602","descriptor_name":"Cytotoxicity, Immunologic","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004305","descriptor_name":"Dose-Response Relationship, Drug","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004353","descriptor_name":"Drug Evaluation, Preclinical","qualifier_ui":"Q000379","qualifier_name":"methods","is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007156","descriptor_name":"Immunologic Memory","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007167","descriptor_name":"Immunotherapy","qualifier_ui":"Q000379","qualifier_name":"methods","is_major_topic":false},{"descriptor_ui":"D007371","descriptor_name":"Interferon-gamma","qualifier_ui":"Q000096","qualifier_name":"biosynthesis","is_major_topic":false},{"descriptor_ui":"D007371","descriptor_name":"Interferon-gamma","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":false},{"descriptor_ui":"D008810","descriptor_name":"Mice, Inbred C57BL","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009368","descriptor_name":"Neoplasm Transplantation","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D010051","descriptor_name":"Ovarian Neoplasms","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":false},{"descriptor_ui":"D010051","descriptor_name":"Ovarian Neoplasms","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D010051","descriptor_name":"Ovarian Neoplasms","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false},{"descriptor_ui":"D010051","descriptor_name":"Ovarian Neoplasms","qualifier_ui":"Q000628","qualifier_name":"therapy","is_major_topic":true},{"descriptor_ui":"D014407","descriptor_name":"Tumor Cells, Cultured","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016176","descriptor_name":"T-Lymphocyte Subsets","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":false},{"descriptor_ui":"D044767","descriptor_name":"Ubiquitin-Protein Ligases","qualifier_ui":"Q000172","qualifier_name":"deficiency","is_major_topic":true},{"descriptor_ui":"D060908","descriptor_name":"CTLA-4 Antigen","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":true}],"locations_count":3,"locations":[{"id":"doi:10.1158/2326-6066.cir-15-0044","doi":"https://doi.org/10.1158/2326-6066.cir-15-0044","is_oa":false,"landing_page_url":"https://doi.org/10.1158/2326-6066.cir-15-0044","pdf_url":null,"source":{"id":"https://openalex.org/S2765010658","display_name":"Cancer Immunology Research","issn_l":"2326-6066","issn":["2326-6066","2326-6074"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Immunology Research","raw_type":"journal-article"},{"id":"pmid:26138335","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/26138335","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer immunology research","raw_type":"Journal Article"},{"id":"pmh:oai:pubmedcentral.nih.gov:4984269","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC4984269/","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"Cancer Immunol Res","raw_type":"Text"}],"best_oa_location":{"id":"pmh:oai:pubmedcentral.nih.gov:4984269","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC4984269/","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"Cancer Immunol Res","raw_type":"Text"},"sustainable_development_goals":[{"display_name":"Good health and well-being","score":1.0,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[{"id":"https://openalex.org/G2797049118","display_name":"Biology of Infectious Disease and Inflammation","funder_award_id":"T32AI007538","funder_id":"https://openalex.org/F4320337355","funder_display_name":"National Institute of Allergy and Infectious Diseases"},{"id":"https://openalex.org/G9000917881","display_name":"Abramson Cancer Center Support Grant","funder_award_id":"P30CA016520","funder_id":"https://openalex.org/F4320337351","funder_display_name":"National Cancer Institute"}],"funders":[{"id":"https://openalex.org/F4320337351","display_name":"National Cancer Institute","ror":"https://ror.org/040gcmg81"},{"id":"https://openalex.org/F4320337355","display_name":"National Institute of Allergy and Infectious Diseases","ror":"https://ror.org/043z4tv69"}],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":52,"referenced_works":["https://openalex.org/W1606500885","https://openalex.org/W1849671624","https://openalex.org/W1967889234","https://openalex.org/W1973268287","https://openalex.org/W1979313505","https://openalex.org/W1979966334","https://openalex.org/W1989362916","https://openalex.org/W1989991921","https://openalex.org/W1996237158","https://openalex.org/W1998514802","https://openalex.org/W2009007206","https://openalex.org/W2011774966","https://openalex.org/W2012104766","https://openalex.org/W2019870545","https://openalex.org/W2042227848","https://openalex.org/W2055260228","https://openalex.org/W2066671159","https://openalex.org/W2079018735","https://openalex.org/W2079220522","https://openalex.org/W2079707111","https://openalex.org/W2080083579","https://openalex.org/W2081269876","https://openalex.org/W2094916265","https://openalex.org/W2095061901","https://openalex.org/W2097995306","https://openalex.org/W2098454071","https://openalex.org/W2098737737","https://openalex.org/W2102862705","https://openalex.org/W2102971019","https://openalex.org/W2104885590","https://openalex.org/W2104945248","https://openalex.org/W2105459360","https://openalex.org/W2112818491","https://openalex.org/W2115247417","https://openalex.org/W2118808185","https://openalex.org/W2119896120","https://openalex.org/W2126510920","https://openalex.org/W2126795725","https://openalex.org/W2130078242","https://openalex.org/W2136722399","https://openalex.org/W2141610024","https://openalex.org/W2141695710","https://openalex.org/W2143467222","https://openalex.org/W2155189639","https://openalex.org/W2160466424","https://openalex.org/W2161693332","https://openalex.org/W2164720040","https://openalex.org/W2166571825","https://openalex.org/W2168372891","https://openalex.org/W2171249989","https://openalex.org/W2560367415","https://openalex.org/W6636205973"],"related_works":["https://openalex.org/W7220942757","https://openalex.org/W1999609445","https://openalex.org/W2891481842","https://openalex.org/W3094072016","https://openalex.org/W2977679546","https://openalex.org/W2955624827","https://openalex.org/W4313408086","https://openalex.org/W3194232904","https://openalex.org/W2740632734","https://openalex.org/W4398225524"],"abstract_inverted_index":{"Immune":[0],"checkpoint":[1,31,57],"blockade":[2,204],"has":[3],"shown":[4],"significant":[5,214],"therapeutic":[6],"efficacy":[7],"in":[8,16,95,117,124,145,149,171,178,186,217],"melanoma":[9],"and":[10,33,121,141,213,222],"other":[11],"solid":[12],"tumors,":[13],"but":[14,106],"results":[15,200],"ovarian":[17,38,51,69,236],"cancer":[18,70,189],"have":[19],"been":[20],"limited.":[21],"With":[22],"evidence":[23],"that":[24,36,49,103,202],"tumor":[25,119,152,220],"immunogenicity":[26],"modulates":[27],"the":[28,113,150,172,179,192,218],"response":[29,45],"to":[30,56,72,229],"blockade,":[32,109],"data":[34],"indicating":[35],"BRCA-deficient":[37],"cancers":[39],"express":[40],"higher":[41],"levels":[42,183],"of":[43,127,135,155,167,175,181,184,195,226],"immune":[44,157],"genes,":[46],"we":[47,63],"hypothesized":[48],"BRCA(-)":[50],"tumors":[52],"would":[53],"be":[54],"vulnerable":[55],"blockade.":[58],"To":[59],"test":[60],"this":[61,136,196,227],"hypothesis,":[62],"used":[64],"an":[65],"immunocompetent":[66],"BRCA1-deficient":[67],"murine":[68],"model":[71],"compare":[73],"treatment":[74,197],"with":[75,83,112,206,234],"CTLA-4":[76,104,203],"or":[77,81],"PD-1/PD-L1":[78,108],"antibodies":[79],"alone":[80],"combined":[82,205],"targeted":[84],"cytotoxic":[85,173],"therapy":[86],"using":[87,97],"a":[88,125],"PARP":[89,114,176,207],"inhibitor.":[90],"Correlative":[91],"studies":[92],"were":[93],"performed":[94],"vitro":[96],"human":[98,187],"BRCA1(-)":[99,188,219],"cells.":[100],"We":[101],"found":[102],"antibody,":[105],"not":[107],"synergized":[110],"therapeutically":[111],"inhibitor,":[115],"resulting":[116],"immune-mediated":[118],"clearance":[120],"long-term":[122],"survival":[123,133,215],"majority":[126],"animals":[128],"(P":[129],"<":[130],"0.0001).":[131],"The":[132],"benefit":[134,216],"combination":[137],"was":[138,159],"T-cell":[139],"mediated":[140],"dependent":[142],"on":[143],"increases":[144,170],"local":[146],"IFN\u03b3":[147,185],"production":[148],"peritoneal":[151],"environment.":[153],"Evidence":[154],"protective":[156,210],"memory":[158],"observed":[160],"more":[161],"than":[162],"60":[163],"days":[164],"after":[165],"completion":[166],"therapy.":[168],"Similar":[169],"effect":[174],"inhibition":[177,208],"presence":[180],"elevated":[182],"cells":[190],"support":[191,223],"translational":[193],"potential":[194],"protocol.":[198],"These":[199],"demonstrate":[201],"induces":[209],"antitumor":[211],"immunity":[212],"model,":[221],"clinical":[224],"testing":[225],"regimen":[228],"improve":[230],"outcomes":[231],"for":[232],"women":[233],"hereditary":[235],"cancer.":[237]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2106910596","counts_by_year":[{"year":2026,"cited_by_count":8},{"year":2025,"cited_by_count":17},{"year":2024,"cited_by_count":20},{"year":2023,"cited_by_count":23},{"year":2022,"cited_by_count":34},{"year":2021,"cited_by_count":41},{"year":2020,"cited_by_count":35},{"year":2019,"cited_by_count":36},{"year":2018,"cited_by_count":33},{"year":2017,"cited_by_count":23},{"year":2016,"cited_by_count":22}],"updated_date":"2026-11-16T12:05:36.265796","created_date":"2016-06-24T00:00:00"}
